12.51美元0.23(1.87%)
2024/10/11更新
績效 / 1月0.64%
3月1.03%
1年17.46%
晨星評等 - 1.現金3.06%
- 2.股票15.47%
- 3.債券0.00%
- 4.其他81.47%
- 1.美國82.69%
- 2.英國6.72%
- 3.歐洲不包含歐元區6.26%
- 4.歐元區1.94%
- 5.加拿大0.54%
- 1.Regeneron Pharmaceuticals Inc8.45%
- 2.Amgen Inc8.43%
- 3.Vertex Pharmaceuticals Inc7.21%
- 4.Eli Lilly and Co5.39%
- 5.AstraZeneca PLC5.08%
- 6.Gilead Sciences Inc4.02%
- 7.Insmed Inc3.28%
- 8.Moderna Inc3.26%
- 9.Novo Nordisk A/S Class B2.76%
- 10.Alnylam Pharmaceuticals Inc2.74%
- 1.現金3.06%
- 2.股票15.47%
- 3.債券0.00%
- 4.其他81.47%
- 1.美國82.69%
- 2.英國6.72%
- 3.歐洲不包含歐元區6.26%
- 4.歐元區1.94%
- 5.加拿大0.54%
- 1.Regeneron Pharmaceuticals Inc8.45%
- 2.Amgen Inc8.43%
- 3.Vertex Pharmaceuticals Inc7.21%
- 4.Eli Lilly and Co5.39%
- 5.AstraZeneca PLC5.08%
- 6.Gilead Sciences Inc4.02%
- 7.Insmed Inc3.28%
- 8.Moderna Inc3.26%
- 9.Novo Nordisk A/S Class B2.76%
- 10.Alnylam Pharmaceuticals Inc2.74%